Latest News
Middle-market investment bank Baird has released a report anticipating a new wave of M&A within the European for-profit education sector.
The report identifies a backlog of more than 50 for-profit education M&A opportunities across Europe and details how the sector is transforming, presenting opportunities for businesses to grow rapidly.
Noting Graphite Capital’s 5.8x return on its sale of Education Personnel and Palamon Capital Partners’ 14.6x return on its sale of Cambridge Education Group, Baird concludes that investors who understand the sector and the business models are well-positioned to generate attractive returns.
Since the start of 2013, there have
Excelsior Capital Partners has provided a USD20 million mezzanine facility to California TrusFrame (CTF) in conjunction with a USD30 million senior credit facility furnished by senior lenders.
Based in Riverside, California with plants that serve clients in California, Nevada and Arizona, CTF is a manufacturer of roof trusses, floor trusses and wall components for commercial, residential and multi-family construction.
Excelsior’s investment in the company supplies the necessary capital for the company to purchase equipment, fund working capital growth, pursue new business ventures and expand into new markets.
“CEO John Hanna and his team have done an excellent job
Asia Climate Partners (ACP), a joint venture by the Asian Development Bank, ORIX Corporation and Robeco Institutional Asset Management, has launched its headquarters in Hong Kong.
“We are pleased to announce the opening of our new headquarters office, which represents another milestone in our continuing efforts to establish the leading private equity platform in developing Asia targeting growth capital investments across a variety of climate-related industries including renewable energy, energy efficiency, environmental services, and agribusiness. We see significant opportunities in these sectors that are structured to generate attractive risk-adjusted returns while concurrently delivering positive environmental and social impacts,” says Todd Freeland, director
V-Rooms has announced the pre-launch of Global Deal Market, a rated deal marketplace exclusively for family office direct investments in private US based mature companies, typically with annual up to USD100 million.
With this pre-launch, Global Deal Market (GDM) is actively reviewing M&A deals for presentation to its Charter Member Investors. With the public launch in January, GDM will present a wide assortment of deals to over 300 family offices.
Global Deal Market will be a deal rating and matching service for partnered family office investors and ultra high-net-worth individuals who are interested in owning private US based mature
Tim Burke has joined Castanea Partners, a private equity firm focused on investing in branded consumer products and services, as a partner.
Rob Smith, a managing partner of Castanea, says: “Tim is an experienced private equity professional and consumer investor and we’re very excited to have him on our team. As a senior investor, Tim has extensive experience in all aspects of middle market investment sourcing, execution, and post acquisition management. He brings with him an extensive network of industry relationships including entrepreneurs, business owners, and investment bankers. Tim’s extensive knowledge and network in the consumer sector will help us
Cirque Energy has entered into a USD5 million common stock purchase agreement with Kodiak Capital Group, a Newport Beach, California-based institutional investor.
Cirque has agreed to file a registration statement with the US Securities and Exchange Commission covering the shares that may be issued to Kodiak under the terms of the common stock purchase agreement.
After the SEC has declared the registration statement related to the transaction effective, Cirque will have the right at its sole discretion over a period of one year to sell up to USD5 million of common stock under the terms set forth in the
Carne Group has received authorisation for an independent AIFMD-compliant management company in the Channel Islands.
The new management company has become immediately operational with Carne Group’s fund clients. It is particularly suitable for alternative fund managers, including credit, hedge fund, private equity, infrastructure and real estate investment firms.
Carne has received authorisation as a fund services business from the Jersey regulator, the Jersey Financial Services Commission (JFSC).
Carne already has over 20 clients making use of its AIFMD management company solutions in Ireland and Luxembourg. The Jersey management company is the first to be approved outside the European
Advent Life Sciences has closed its Advent Life Sciences Fund II (ALSF II), a GBP145.5 million (USD235 million) venture capital fund raised to seed and build life sciences companies in the UK, Europe and the US.
The fund will back entrepreneurs and early-stage and mid-stage companies with the potential to deliver first- or best-in-class breakthrough products for unmet medical needs.
The fund, which quickly exceeded its target, was raised entirely from independent financial investors including funds-of-funds, pension funds, and family offices.
“We thank our returning and new LPs for the strength of their support, which allowed us to
Infracapital, the infrastructure investment arm of M&G Investments and parent Prudential plc, has reached a final closing of its latest fund, Infracapital Partners II, with total commitments of GBP1.0 billion (USD1.6 billion).
Co-investment pledges take the total investable funds to over GBP1.3 billion. As with its predecessor, Infracapital Partners LP, the fund’s strategy is to invest in, and actively manage, core infrastructure assets across Europe.
The fundraising, which exceeded its initial target, received strong backing from existing investors and in addition welcomed a number of new investors from across Europe, North America and Asia. In addition to seed capital
Private equity firm GTCR is to sell portfolio company Devicor Medical Products to Danaher Corporation’s Leica Biosystems, a provider of anatomical pathology solutions and automation used to advance cancer diagnostics.
Devicor is a medical device company specialising in products for use in breast biopsy procedures. The company is the global market leader in the vacuum-assisted biopsy segment of the breast biopsy market. Its products include the Mammotome Breast Biopsy System, tissue markers and related products, which, to date, have enabled more than four million women to have a minimally invasive breast biopsy.
Devicor began as a management partnership formed
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
